loadpatents
name:-0.020710945129395
name:-0.021152019500732
name:-0.0016450881958008
Boucher; Richard C. Patent Filings

Boucher; Richard C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boucher; Richard C..The latest application filed is for "dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases".

Company Profile
1.20.21
  • Boucher; Richard C. - Chapel Hill NC
  • BOUCHER; Richard C. - Durham NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 10,526,292 - Johnson , et al. J
2020-01-07
Methods of treatment
Grant 10,335,558 - Boucher , et al.
2019-07-02
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 9,987,443 - Boucher , et al. June 5, 2
2018-06-05
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20180111907 - Johnson; Michael Ross ;   et al.
2018-04-26
Sodium Channel Blockers For Skin Disorders
App 20180092915 - Johnson; Michael Ross ;   et al.
2018-04-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 9,878,988 - Johnson , et al. January 30, 2
2018-01-30
Sodium channel blockers for skin disorders
Grant 9,849,129 - Johnson , et al. December 26, 2
2017-12-26
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20170151396 - BOUCHER; Richard C. ;   et al.
2017-06-01
Sodium Channel Blockers For Skin Disorders
App 20170020870 - Johnson; Michael Ross ;   et al.
2017-01-26
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 9,408,988 - Boucher , et al. August 9, 2
2016-08-09
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20160122306 - JOHNSON; Michael Ross ;   et al.
2016-05-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 9,260,398 - Johnson , et al. February 16, 2
2016-02-16
Novel Mucolytic Agents
App 20150307530 - JOHNSON; Michael R. ;   et al.
2015-10-29
Methods Of Treatment
App 20150101597 - BOUCHER; Richard C. ;   et al.
2015-04-16
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20150099764 - JOHNSON; Michael Ross ;   et al.
2015-04-09
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 8,980,898 - Johnson , et al. March 17, 2
2015-03-17
Methods of treatment
Grant 8,778,383 - Boucher , et al. July 15, 2
2014-07-15
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20140096765 - BOUCHER; Richard C. ;   et al.
2014-04-10
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20130324559 - JOHNSON; Michael Ross ;   et al.
2013-12-05
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 8,551,534 - Boucher , et al. October 8, 2
2013-10-08
Methods Of Treatment
App 20130074842 - Boucher; Richard C. ;   et al.
2013-03-28
Pyrazinoylguanidine compounds for use as taste modulators
Grant 8,288,391 - Johnson , et al. October 16, 2
2012-10-16
Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
Grant 8,163,758 - Johnson , et al. April 24, 2
2012-04-24
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
Grant 8,058,278 - Johnson , et al. November 15, 2
2011-11-15
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
Grant 7,981,898 - Johnson , et al. July 19, 2
2011-07-19
Phenyl Substituted Pyrazinoylguanidine Sodium Channel Blockers Possessing Beta Agonist Activity
App 20110008268 - Johnson; Michael Ross ;   et al.
2011-01-13
Multiple Nebulizer Systems
App 20100074881 - BOUCHER; Richard C. ;   et al.
2010-03-25
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20090104272 - BOUCHER; Richard C. ;   et al.
2009-04-23
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes
App 20090082287 - Johnson; Michael Ross ;   et al.
2009-03-26
Method Of Treating Acid-sensing Ion Channel Mediated Pain, Cough Suppression, And Central Nervous System Disorders
App 20080293740 - JOHNSON; Michael R. ;   et al.
2008-11-27
Pyrazinoylguanidine Compounds For Use As Taste Modulators
App 20080249109 - JOHNSON; Michael R. ;   et al.
2008-10-09
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes
App 20080090841 - Johnson; Michael Ross ;   et al.
2008-04-17
Method of treating bronchitis with uridine triphosphate and related compounds
Grant 6,159,952 - Shaffer , et al. December 12, 2
2000-12-12
Methods of treating lung disease by an aerosol containing benzamil or phenamil
Grant 5,656,256 - Boucher , et al. August 12, 1
1997-08-12
Methods of detecting compounds which bind to the P.sub.2U receptor
Grant 5,607,836 - Boucher , et al. March 4, 1
1997-03-04
Aerosolized amiloride treatment of retained pulmonary secretions
Grant 4,501,729 - Boucher , et al. February 26, 1
1985-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed